MagCore DNA Extraction and Purification Technology Now Available in the US

Chicago, IL, March 07, 2017 --(PR.com)-- RBC Bioscience of Taipei, Taiwan, manufacturer of the MagCore® nucleic acid extraction and purification system and Parallel Devices, a supplier of life science sample preparation products, together announce at PITTCON Conference and Expo 2017, Chicago, IL the availability of the MagCore® product line to bench-researchers in the USA.

Nucleic acid samples such as DNA and RNA are key to many research applications, and RBC Bioscience has developed its popular MagCore instrumentation and reagent platform to assist high throughput molecular diagnostic laboratories with convenient and economic and sample processing capabilities.

Parallel Devices serves life science laboratories in the USA and now supplies to its customers on the West Coast of the US MagCore Automated Nucleic Acid Extractors and all MagCore Nucleic Acid Extraction kits. This combination of reliable instrumentation platform with ready-to-go cartridges provides true walk-away automation for laboratories that need to extract nucleic acids from 1 to 48 raw material samples in parallel. The application-specific reagent kits and associated instrument protocols provide the basis for high-yield and high-quality nucleic acid preparations from a wide range of raw materials, such as animal tissue, cultivated bacteria, yeast or eukaryotic cells, blood, cell free body fluids as well as forensic samples.

Margot Specht, General Manager of Parallel Devices said: "We are proud RBC Bioscience has chosen us to distribute MagCore products. We are particularly excited to introduce the MagCore Super instrument to demanding users because of its unique functionality, not only extracting and purifying, but also measuring concentration and quality of the resulting ultrapure nucleic acid. The instrument/kit combination provides busy labs with a substantial return on investment."

David Cho, founder and Managing Director of RBC Bioscience said: "We are delighted to be working with the team at Parallel Devices and expand the reach of our products into North America. With more than 400 systems installed world-wide, our mature MagCore product line makes bench-researchers more productive."

Furthermore, David explained, "We are particularly excited for Parallel Devices to launch our new Forensic DNA Direct Kit, a consumable with patented sample containment technology for fully automatic extraction of nucleic acids from forensic samples. The kit provides cost-effective and high DNA recovery from a wide variety of forensic specimens. Its specially designed, single-use extraction device assures contamination-free and fully contained lysis and DNA extraction. High recovery of pure DNA is achieved by our patented cellulose-coated magnetic affinity beads that do not require phenol or other toxic reagents. A 5 micro liter dry blood spot typically yields 10 ng of pure DNA that is ready for downstream processing by qPCR or Next Generation Sequencing. This distributorship is a further demonstration of our commitment to providing researchers world-wide with innovative products so they can gain research results at reasonable cost."